Jan 6, 2026
Modified-Release Formulations: Key Bioequivalence Requirements You Need to Know
Tag: biologics
Insurance Coverage of Biosimilars: How Prior Authorization and Tier Placement Block Affordability
Read More
Biosimilars offer major cost savings over brand-name biologics, but insurance barriers like prior authorization and same-tier placement make them hard to access. Patients pay nearly the same out-of-pocket costs - defeating the purpose.
